Ocular implant project receives €1.4 million

Article

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

BIOSURF, a research project to develop ocular implants, has been awarded a Ocular implant project receives €1.4 million grant by German Minister Dr Schavan.

The grant has been issued to alamedics, Offenhäuser & Berger, the Max-Planck Institute for Intelligent Systems and the Laser Institute in order to develop a new generation of ocular implants for glaucoma.

Dr Christian Lingenfelder, general manager of alamedics and coordinator of the project group, explained, "The implants will allow for better control of intraocular pressure. The newly designed surfaces of artificial intraocular lenses, a combination of innovative materials and nanostructures, will allow for significantly better night vision. Additionally, the interaction of implant and body after implantation will be much better controlled."

Dr Schavan commented, "The BIOSURF research group over the next three years wants to explore new biomaterials and to create nanostructures, which allow controlled interaction of the human body with the implants. To better control the function and durability of the implant, the biomimetic structures researched in this project, will support regeneration of the interface between implant and body."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.